{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:46:00Z","timestamp":1792820760094,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Zambia recently achieved UNAIDS 90-90-90 treatment targets for HIV epidemic control; however, inpatient facilities continue to face a large burden of patients with advanced HIV disease and HIV-related mortality. Management of advanced HIV disease, following guidelines from outpatient settings, may be more difficult within complex inpatient settings. We evaluated adherence to HIV guidelines during hospitalization, including opportunistic infection (OI) screening, treatment, and prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed inpatient medical records of people living with HIV (PLHIV) admitted to the University Teaching Hospital in Lusaka, Zambia between December 1, 2018 and April 30, 2019. We collected data on patient demographics, antiretroviral therapy (ART), HIV biomarkers, and OI screening and treatment\u2014including tuberculosis (TB), Cryptococcus, and OI prophylaxis with co-trimoxazole (CTX). Screening and treatment cascades were constructed based on the 2017 WHO Advanced HIV Guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We reviewed files from 200 charts of patients with advanced HIV disease; of these 92% (184\/200) had been on ART previously; 58.1% (107\/184) for more than 12\u00a0months. HIV viral load (VL) testing was uncommon but half of VL results were high. 39% (77\/200) of patients had a documented CD4 count result. Of the 172 patients not on anti-TB treatment (ATT) on admission, TB diagnostic tests (either sputum Xpert MTB\/RIF MTB\/RIF or urine TB-LAM) were requested for 105 (61%) and resulted for 60 of the 105 (57%). Nine of the 14 patients (64%) with a positive lab result for TB died before results were available. Testing for Cryptococcosis was performed predominantly in patients with symptoms of meningitis. Urine TB-LAM testing was rarely performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>At a referral hospital in Zambia, CD4 testing was inconsistent due to laboratory challenges and this reduced recognition of AHD and implementation of AHD guidelines. HIV programs can potentially reduce mortality and identify PLHIV with retention and adherence issues through strengthening inpatient activities, including reflex VL testing, TB-LAM and serum CrAg during hospitalization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-022-00433-8","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T06:03:19Z","timestamp":1645509799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Advanced HIV disease management practices within inpatient medicine units at a referral hospital in Zambia: a retrospective chart review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3309-0538","authenticated-orcid":false,"given":"Nyuma","family":"Mbewe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Vinikoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sombo","family":"Fwoloshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mundia","family":"Mwitumwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir","family":"Lakhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suilanji","family":"Sivile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallika","family":"Yavatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lottie","family":"Hachaambwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Mulenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassidy W.","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"issue":"66","key":"433_CR1","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1093\/cid\/ciy045","volume":"4","author":"S Carmona","year":"2018","unstructured":"Carmona S, Bor J, Nattey C, Maughan-Brown B, Maskew M, Fox MP, et al. Persistent high burden of advanced HIV disease among patients seeking care in South Africa\u2019s National HIV Program: data from a Nationwide Laboratory Cohort. Clin Infect Dis. 2018;4(66):S111\u20137.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"433_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofz336","volume":"6","author":"L Haachambwa","year":"2019","unstructured":"Haachambwa L, Kandiwo N, Zulu PM, Rutagwera D, Geng E, Holmes CB, et al. Care continuum and postdischarge outcomes among HIV-infected adults admitted to the hospital in Zambia. Open Forum Infect Dis. 2019;6(10):1\u20136.","journal-title":"Open Forum Infect Dis"},{"issue":"15","key":"433_CR3","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/QAD.0000000000002627","volume":"34","author":"R Lebelonyane","year":"2020","unstructured":"Lebelonyane R, Mills LA, Mogorosi C, Ussery F, Marukutira T, Theu J, et al. Advanced HIV disease in the Botswana combination prevention project: prevalence, risk factors, and outcomes. AIDS. 2020;34(15):2223\u201330.","journal-title":"AIDS"},{"key":"433_CR4","unstructured":"UNAIDS. UNAIDS State of the epidemic. UNAIDS 2018 Reference. 2018."},{"issue":"10","key":"433_CR5","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.1016\/S2352-3018(21)00152-1","volume":"8","author":"D Jahagirdar","year":"2021","unstructured":"Jahagirdar D, Walters MK, Novotney A, Brewer ED, Frank TD, Carter A, et al. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990\u20132019, for 204 countries and territories: the Global Burden of Diseases Study 2019. Lancet HIV. 2021;8(10):e633\u201351.","journal-title":"Lancet HIV"},{"issue":"7","key":"433_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jia2.25546","volume":"23","author":"E Zaniewski","year":"2020","unstructured":"Zaniewski E, Dao Ostinelli CH, Chammartin F, Maxwell N, Davies MA, Euvrard J, et al. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa. J Int AIDS Soc. 2020;23(7):1\u201310.","journal-title":"J Int AIDS Soc"},{"key":"433_CR7","doi-asserted-by":"crossref","unstructured":"Kerkhoff AD, Sikombe K, Eshun-Wilson I, Sikazwe I, Glidden D V., Pry JM, et al. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: a cohort study. PLoS Med. 2020;17(5).","DOI":"10.1371\/journal.pmed.1003107"},{"key":"433_CR8","doi-asserted-by":"crossref","unstructured":"Workie KL, Birhan TY, Angaw DA. Predictors of mortality rate among adult HIV-positive patients on antiretroviral therapy in Metema Hospital, Northwest Ethiopia: a retrospective follow-up study. AIDS Res Ther. 2021;18(1).","DOI":"10.1186\/s12981-021-00353-z"},{"key":"433_CR9","doi-asserted-by":"crossref","unstructured":"Dawood H, Hassan-Moosa R, Zuma NY, Naidoo K. Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa. BMC Infect Dis. 2018;18(1).","DOI":"10.1186\/s12879-018-3083-z"},{"key":"433_CR10","unstructured":"World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Licence: CC BY-NC-SA 3.0 IGO. [Internet]. 2017. 1\u201356 p. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/255884\/1\/9789241550062-eng.pdf?ua=1."},{"issue":"66","key":"433_CR11","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1093\/cid\/cix1139","volume":"4","author":"N Ford","year":"2018","unstructured":"Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, et al. Managing advanced HIV disease in a public health approach. Clin Infect Dis. 2018;4(66):S106\u201310.","journal-title":"Clin Infect Dis"},{"key":"433_CR12","unstructured":"MOH GRZ. Guidelines for Treatment and Prevention of HIV Infection. 2020."},{"issue":"9983","key":"433_CR13","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","volume":"385","author":"S Mfinanga","year":"2015","unstructured":"Mfinanga S, Chanda D, Kivuyo SL, Guinness L, Bottomley C, Simms V, et al. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet. 2015;385(9983):2173\u201382.","journal-title":"Lancet"},{"issue":"1","key":"433_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-016-0106-y","volume":"13","author":"W Manosuthi","year":"2016","unstructured":"Manosuthi W, Wiboonchutikul S, Sungkanuparph S. Integrated therapy for HIV and tuberculosis. AIDS Res Ther. 2016;13(1):1\u201312.","journal-title":"AIDS Res Ther"},{"issue":"3","key":"433_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1615822","volume":"377","author":"J Hakim","year":"2017","unstructured":"Hakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C, et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. N Engl J Med. 2017;377(3):233\u201345.","journal-title":"N Engl J Med"},{"issue":"9","key":"433_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med [Internet]. 2016;375(9):830\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1600693.","journal-title":"N Engl J Med [Internet]."},{"key":"433_CR17","unstructured":"MOH GRZ. Zambia consolidated guidelines for Treatment and Prevention of HIV infection. 2018."},{"key":"433_CR18","unstructured":"Meya DB. Establishing targets for advanced HIV disease: a call to action. 1\u20135."},{"issue":"13","key":"433_CR19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2017.10913","volume":"318","author":"B Andrews","year":"2017","unstructured":"Andrews B, Semler MW, Muchemwa L, Kelly P, Lakhi S, Heimburger DC, et al. Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA J Am Med Assoc. 2017;318(13):1233\u201340.","journal-title":"JAMA J Am Med Assoc"},{"key":"433_CR20","unstructured":"Barr DA, Lewis JM, Feasey N, Schutz C, Kerkhoff AD, Jacob ST, et al. Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data. Lancet Infect Dis. 2020;1\u201311."},{"issue":"11","key":"433_CR21","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","volume":"378","author":"SF Molloy","year":"2018","unstructured":"Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, et al. Antifungal combinations for treatment of cryptococcal meningitis in Africa. N Engl J Med. 2018;378(11):1004\u201317.","journal-title":"N Engl J Med"},{"key":"433_CR22","doi-asserted-by":"crossref","unstructured":"Global Aids Monitoring 2019. Country progress report\u2014Zambia. 2019;","DOI":"10.5089\/9781513523538.002"},{"issue":"4","key":"433_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4314\/mmj.v28i4.6","volume":"28","author":"A Craik","year":"2016","unstructured":"Craik A, Patel P, Patel P, Mallewa J, Malisita K, Bitilinyu-Bangoh J, et al. Challenges with targeted viral load testing for medical inpatients at Queen Elizabeth Central Hospital in Blantyre, Malawi. Malawi Med J. 2016;28(4):179\u201381.","journal-title":"Malawi Med J"},{"key":"433_CR24","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/ciw001","volume":"62","author":"T Roberts","year":"2016","unstructured":"Roberts T, Cohn J, Bonner K, Hargreaves S. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis. 2016;62:1043\u20138.","journal-title":"Clin Infect Dis"},{"issue":"January","key":"433_CR25","first-page":"2017","volume":"216","author":"E Raizes","year":"2018","unstructured":"Raizes E, Hader S, Birx D. The US President\u2019s Emergency Plan for AIDS relief (PEPFAR) and HIV drug resistance: mitigating risk. Monit Impact. 2018;216(January):2017\u20139.","journal-title":"Monit Impact"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-022-00433-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-022-00433-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-022-00433-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T06:23:10Z","timestamp":1645510990000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-022-00433-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1186\/s12981-022-00433-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1042337\/v1","asserted-by":"object"}]},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by UTH, the University of Zambia Biomedical Research Ethics Committee (REF. NO. 012-02-19), the University of Maryland Baltimore institutional review board (IRB) (FWA#00007145), and the National Health Research Authority. A waiver of informed consent was obtained from the IRBs and no patient identifiers were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}